These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6177952)
1. The nitroglycerin polymer gel matrix system: a new method for administering nitroglycerin evaluated with plasma nitroglycerin levels. Colfer H; Stetson P; Lucchesi BR; Wagner J; Pitt B J Cardiovasc Pharmacol; 1982; 4(3):521-5. PubMed ID: 6177952 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and hormonal response to transdermal nitroglycerin in normal subjects and in patients with congestive heart failure. Olivari MT; Carlyle PF; Levine TB; Cohn JN J Am Coll Cardiol; 1983 Nov; 2(5):872-8. PubMed ID: 6415142 [TBL] [Abstract][Full Text] [Related]
3. Sustained beneficial hemodynamic responses to large doses of transdermal nitroglycerin in congestive heart failure and comparison with intravenous nitroglycerin. Rajfer SI; Demma FJ; Goldberg LI Am J Cardiol; 1984 Jul; 54(1):120-5. PubMed ID: 6430054 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the safety and efficacy of topical nitroglycerin ointment to facilitate venous cannulation. Griffith P; James B; Cropp A Nurs Res; 1994; 43(4):203-6. PubMed ID: 8047423 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure. Armstrong PW J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600 [TBL] [Abstract][Full Text] [Related]
6. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. Jordan RA; Seth L; Casebolt P; Hayes MJ; Wilen MM; Franciosa J Ann Intern Med; 1986 Mar; 104(3):295-8. PubMed ID: 3080935 [TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin concentration in plasma: comparison between transdermal therapeutic system and ointment. Chu LC; Gale RM; Schmitt LG; Shaw JE Angiology; 1984 Sep; 35(9):545-52. PubMed ID: 6435484 [TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers. Imhof PR; Sieber A; Hodler J; Müller P; Ott B; Fankhauser P; Chu LC; Gérardin A Eur J Clin Pharmacol; 1982; 23(2):99-106. PubMed ID: 6814928 [TBL] [Abstract][Full Text] [Related]
9. Human pharmacological studies of a new transdermal system containing nitroglycerin. Müller P; Imhof PR; Burkart F; Chu LC; Gérardin A Eur J Clin Pharmacol; 1982; 22(6):473-80. PubMed ID: 6813125 [TBL] [Abstract][Full Text] [Related]
10. Relation of time course of plasma nitroglycerin levels to echocardiographic, arterial pressure and heart rate changes after sublingual administration of nitroglycerin. Wei JY; Reid PR Am J Cardiol; 1981 Oct; 48(4):778-82. PubMed ID: 6792895 [TBL] [Abstract][Full Text] [Related]
11. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid. McAllister A; Mosberg H; Settlage JA; Steiner JA Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698 [TBL] [Abstract][Full Text] [Related]